Lioresal (Baclofen)

Baclofen works by binding to GABA_B receptors in the spinal cord. This activation inhibits the release of excitatory neurotransmitters and reduces neuronal firing, leading to a decrease in reflex‑mediated muscle contraction and consequently lowering spasticity.

The dosage of Lioresal is individualized. The prescribing clinician determines the appropriate dose based on the patient’s specific condition, therapeutic response, and tolerability, and may adjust it gradually to achieve optimal control of spasticity.

Safety data for baclofen in pregnancy and lactation are limited. It is classified as having an unknown pregnancy category and is known to be excreted in breast milk. Use only if the potential benefit justifies the potential risk to the fetus or infant.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lioresal (baclofen) is a GABA_B agonist, whereas alternatives such as tizanidine act on α2‑adrenergic receptors and diazepam enhances GABA_A activity. Baclofen is often preferred for its targeted spinal action and lower risk of dependence, but individual response and side‑effect profiles vary.

Lioresal tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the container tightly closed and out of reach of children.

Lioresal is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, with or without food, as directed by the prescriber. Doses are usually titrated gradually to minimize side effects.

Serious adverse events include seizures, hallucinations, severe hypotension, and respiratory depression. These reactions are uncommon but require immediate medical attention. Patients should be monitored closely, especially when initiating therapy or adjusting the dose.

Lioresal is contraindicated in individuals with known hypersensitivity to baclofen or any tablet excipients. Caution is advised in patients with severe renal impairment, uncontrolled epilepsy, or those concurrently using other central nervous system depressants.